Citius Oncology Inc (CTOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,765 | -14,395 | -6,659 | -21,149 | -14,336 |
| Income taxes - deferred | 793 | 529 | 264 | 576 | 432 |
| Accounts payable and accrued liabilities | 4,956 | 3,965 | 2,163 | 2,423 | -1,289 |
| Other Working Capital | 12,950 | 9,969 | 4,587 | 13,200 | 8,073 |
| Other Operating Activity | 1,067 | -68 | -355 | 5,076 | 7,120 |
| Operating Cash Flow | $N/A | $0 | $N/A | $126 | $0 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | N/A | N/A | N/A | -5,000 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -5,000 | 0 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-5,000 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 3,800 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 1,074 | 0 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $4,874 | $N/A |
| Net Cash Flow | $N/A | $0 | $N/A | $0 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 0 | N/A | 126 | 0 |
| Free Cash Flow | 0 | 0 | 0 | 126 | 0 |